Health Practitioners Act 2004

Health practitioner is defined broadly in section 4 as “an individual who practises a health profession”. Health profession is defined by reference to section 5 of the Health Practitioner Regulation National Law. Registered means registered under the National Law to practise a health profession (section 4). Pharmacist is a subset: a person registered under the National Law to practise in the pharmacy profession, other than as a student (section 4).

Pharmacy business is defined in Schedule 7, clause 1 as “a business that includes the custody of drugs and medicines, the dispensing of medicines on prescription and the supply of scheduled drugs and poisons to consumers by retail”. Pharmacy service means “a service that includes the custody of drugs and medicines, the dispensing of medicines on prescription and the supply of scheduled drugs and poisons to patients and consumers”. Pharmacy means the premises (or part of premises) where a pharmacy business is carried on; pharmacy department is the premises where a pharmacy service is provided.

Authorised pharmacy business owner means a pharmacist, a partnership of all pharmacists, or a corporation of which all shareholders and directors are pharmacists (Schedule 7, clause 1). Authorised pharmacy service provider means an organisation that operates an Aboriginal health service, a pharmacy service that is part of a public hospital, or a pharmacy service that is part of a defence force facility (clause 1). These concepts are central to the ownership restrictions in clauses 2 and 3.

The Pharmacy Premises Committee (Pharmacy Committee) is established under section 18A as a body corporate. It consists of four members appointed by the Minister: three must be pharmacists able to assist the Committee in its functions, and one must be a person who is not a pharmacist and who can represent patients and consumers of pharmacy services (section 18B(2)). Schedule 2 specifies administrative provisions for members, including term of office (maximum three years, no more than two successive terms without Ministerial approval), vacation of office, and chairperson election. Schedule 3 governs meetings: quorum is three members of whom two must be pharmacists (clause 2(1)); meetings are generally open to the public (clause 6(1)) unless the Committee orders exclusion; the Committee may permit participation by telephone or other means (clause 7(2)); and members must disclose conflicts of interest (clause 5). A member or delegate must not disclose information obtained in the course of duties except as part of those duties (Schedule 3, clause 8), with a maximum penalty of 100 penalty units or six months imprisonment.

Inspector means a person appointed under section 71. Inspectors investigate matters referred by the Pharmacy Committee and have entry and search powers (section 72) and specific investigative powers (section 73), including the power to require answers under section 108(2) despite self-incrimination.

Tribunal means the Civil and Administrative Tribunal (section 4 definition). For matters under this Act or the Health Practitioner Regulation National Law (NT), the Tribunal is constituted as a three-member panel under section 63. This is the body that hears notifications about registered health practitioners and appeals against decisions not to register.

Notification is defined in section 4 by reference to the Health Practitioner Regulation National Law (NT) section 5. It is the mechanism by which concerns about a health practitioner’s conduct, health or performance are brought to the attention of a National Board.

Medical examination in Part 3 includes examination of the physical, psychological and mental capacities of a person (section 66(6)). The Tribunal may require such an examination at the expense of the National Board for the relevant health profession, but only if it is reasonable to do so for the proceeding (section 66(2)).

Declared provision (section 127(9)) means specific clauses of Schedule 7 (2(1), 3, 4(1)/(2), 5(1)/(2), 7(1)/(2)/(3), or 8(1)) or a provision of regulations prescribed. These are the provisions for which executive officers of a body corporate face personal criminal liability if the body corporate contravenes them.

Executive officer of a body corporate means a director or other person who is concerned with or takes part in the management of the body corporate (section 127(9)).

Convicted offenders prohibitions under section 119 involve the Secretary, defined as the Chief Executive Officer of the agency responsible for administering the Act (section 119(11)). The Secretary may prohibit a person convicted of an offence against the Act from operating a business that provides health care services, if satisfied the person is not fit and proper. A double conviction within ten years creates a rebuttable presumption of not fit and proper.

Health care service is defined in section 4 as a service provided by a health practitioner in practising a health profession for which the practitioner is registered, or any other service connected with the provision of health care.

The Act directly affects pharmacists, pharmacy owners, pharmacy employees, consumers and patients, and the executive officers of corporate pharmacy owners. It also affects members of the Pharmacy Committee, inspectors, and the Tribunal.

Pharmacists are at the centre of the regulatory scheme. Only a pharmacist (or a partnership or corporation of pharmacists) may own a pharmacy business (Schedule 7, clause 2(1)). Pharmacists must supervise pharmacies while they are open to the public (clause 5) and may be appointed as pharmacist-in-charge (clause 7) or pharmacy superintendent (clause 8). A pharmacist must not be appointed as pharmacist-in-charge of more than one pharmacy or pharmacy department (clause 7(6)). Pharmacists are also subject to the health practitioner regulatory system under the National Law, to which this Act provides the Tribunal for hearings (Part 3). A pharmacist who is the subject of a notification may be required to undergo a medical examination by the Tribunal (section 66).

Pharmacy business owners - whether individuals, partnerships or corporations - must comply with ownership restrictions (only authorised pharmacy business owners may own a pharmacy business; clause 2). They must ensure that premises comply with standards prescribed by the Pharmacy Committee (clause 4), that a pharmacist is in direct supervision at all times (clause 5), that a pharmacist-in-charge is appointed before opening (clause 7), that the Committee is notified of appointments, and that a pharmacy superintendent is appointed if they own more than one pharmacy (clause 8). Owners face substantial penalties for contraventions: up to 500 penalty units for an individual, 2,500 penalty units for a body corporate for most Schedule 7 offences.

Executive officers of body corporate owners are directly affected by section 127. If a body corporate commits an offence against a declared provision (e.g., owning a pharmacy without being an authorised pharmacy business owner, operating without direct supervision, failing to appoint a pharmacist-in-charge), the executive officer commits a regulatory offence carrying the same maximum penalty as an individual would face. This is a significant personal liability risk. Defences exist, but the burden falls on the executive officer to show they were not in a position to influence, took reasonable steps, or could not have known. Section 127 applies even if the body corporate is not prosecuted (subsection (7)). The provision was inserted by the Statute Law Amendment (Directors’ Liability) Act 2015 and applies only to conduct occurring after its commencement, with the earlier version continuing for pre-2015 conduct (section 159).

Inspectors appointed by the Pharmacy Committee (section 71) exercise powers of entry, search, seizure, and questioning. They must carry identity cards and produce them when exercising powers (section 72(1)). An inspector who ceases to hold office must return their identity card within five days (section 71(4), penalty 5 penalty units). Inspectors are subject to the offence of accepting inducements (section 72(7) - 400 penalty units or two years imprisonment).

Consumers and patients are the ultimate beneficiaries of the Act’s protection. The Pharmacy Committee must include one member who is not a pharmacist and who represents patient and consumer interests (section 18B(2)(b)). Meetings of the Committee are generally open to the public (Schedule 3, clause 6), giving consumers a degree of transparency. Persons who provide information to the Pharmacy Committee in good faith are protected from civil or criminal liability (section 112). The Act also makes it an offence to threaten or intimidate a person who provides information in good faith (section 109, 500 penalty units). The Secretary may prohibit a convicted offender from operating a health care services business (section 119), directly protecting the public from unfit operators.

The Pharmacy Committee itself is affected by requirements for meetings (Schedule 3), disclosure of interests (Schedule 3, clause 5), and confidentiality (Schedule 3, clause 8). Committee members are protected from liability for acts done in good faith (section 18J). The Committee must produce an annual report to the Minister before 31 December each year (section 18K). The Committee may set fees determined by the Minister (section 18L).

The Civil and Administrative Tribunal (the Tribunal) is given functions under this Act, particularly to hear matters referred under the Health Practitioner Regulation National Law (NT) (section 64). The Tribunal’s composition for these matters is prescribed by section 63, and it may deal with additional notifications (section 65) and order medical examinations (section 66). The Tribunal’s jurisdiction overlaps with the former Health Professional Review Tribunal under transitional arrangements in Parts 12 and 13.

The Territory Government is bound by the Act (section 5). The Minister appoints Pharmacy Committee members and may remove them (Schedule 2). The Minister may grant exemptions from pharmacy ownership restrictions to Aboriginal health services and friendly societies (Schedule 7, clause 2(2)). The Minister may determine fees payable to the Pharmacy Committee (section 18L). The Secretary may issue prohibition notices under section 119. The Administrator may make regulations (section 131).

Duty not to own or control a pharmacy business unless authorised. Schedule 7, clause 2(1) prohibits a person from owning or exercising control over a pharmacy business unless the person is an authorised pharmacy business owner (a pharmacist, a partnership of all pharmacists, or a corporation of all pharmacist shareholders and directors) or has been granted an exemption by the Minister. This is the foundational ownership restriction, subject to a maximum penalty of 500 penalty units (individual) or 2,500 penalty units (body corporate). A similar prohibition applies to owning a pharmacy service (clause 3). Exemptions may be granted to Aboriginal health services and friendly societies if the Minister is satisfied that health services will be improved and community needs met (clause 2(2)-(3)). The prohibition does not apply to persons who owned a pharmacy business before 23 February 2005 (clause 2(4)) or to administrators of deceased estates, bankrupts, or companies in administration (clause 2(5)).

Duty to ensure premises comply with prescribed standards. A person must not conduct a pharmacy business or pharmacy service from premises unless the premises comply with standards prescribed by the Pharmacy Committee (clause 4(1) and (2)). This extends to both the physical premises and the operational standards the Committee may set under section 18E. Non-compliance carries the same penalty as the ownership offence (500/2,500 penalty units).

Duty of direct supervision by a pharmacist. The owner of a pharmacy must ensure that the pharmacy is under the direct supervision of a pharmacist at all times while it is open to the public (clause 5(1)). The owner of a pharmacy department must ensure the same while the department is open to dispense drugs or medicine (clause 5(2)). This duty is absolute in the sense that it does not require knowledge or fault on the part of the owner; it is a strict liability offence (the Act does not provide a defence, but general criminal law principles may apply).

Duty to restrict entry to pharmacies. A person must not enter or remain in a pharmacy unless they are a pharmacist or under the direct supervision of a pharmacist (clause 6(1) and (2)). This applies equally to pharmacies and pharmacy departments, with a maximum penalty of 500 penalty units. The restriction is significant for members of the public, employees who are not pharmacists, and tradespeople.

Duty to appoint a pharmacist-in-charge. An authorised pharmacy business owner must not open the pharmacy business to the public unless they have appointed a pharmacist to be pharmacist-in-charge (clause 7(1)). The same applies to a pharmacy service provider opening a pharmacy department (clause 7(3)). The owner must notify the Pharmacy Committee of the appointment as soon as practicable after it is made (clause 7(2) and (4)). A pharmacist cannot be appointed as pharmacist-in-charge of more than one pharmacy or pharmacy department (clause 7(6)). The pharmacist-in-charge is responsible for the conduct of the pharmacy business or service (clause 7(5)).

Duty to appoint a pharmacy superintendent for multiple pharmacies. A person who owns more than one pharmacy or pharmacy department must appoint a pharmacist as pharmacy superintendent (clause 8(1)). Notification to the Committee is required (clause 8(2)). The superintendent is responsible for the conduct of all the pharmacies or departments under their supervision (clause 8(3)).

Duty regarding pharmacy keys. A person must not have keys to a pharmacy or pharmacy department unless they are the pharmacist-in-charge, a pharmacist nominated by the pharmacist-in-charge as a key holder, or authorised by a key holder (clause 9). “Keys” includes devices, codes and any other mechanism to gain access (clause 9(3)). Maximum penalty: 50 penalty units.

Right of the Tribunal to order medical examinations. Section 66(1) gives the Tribunal the power to require a person who is the subject of a matter to undergo one or more medical examinations at the expense of the relevant National Board. The examination must be reasonable for the proceeding (subsection (2)). The notice must specify the examiner’s name, date, time and place, and those details must be reasonable (subsection (3)-(4)). The examiner must provide a written report to the Tribunal and the person examined (subsection (5)). This is not a duty imposed on the health practitioner but a power of the Tribunal; if the person fails to comply, the Act does not specify a penalty, but such failure could lead to adverse inferences.

Right of the Tribunal to deal with additional notifications. Under section 65, if during proceedings for a notification the Tribunal considers that an additional notification could have been made about the same health practitioner, it may treat that additional notification as if it had been referred, and deal with it in the same proceedings (subsection (2)). This avoids the need for separate proceedings and allows the Tribunal to address all relevant concerns comprehensively.

Right of the Pharmacy Committee to issue policies and guidelines. Section 18E allows the Committee to approve a policy or guideline to give practical guidance for complying with Schedule 7. The Committee must publicise the approved policy or guideline as it decides, including on a website. While not binding law, these documents will be highly relevant in assessing compliance and may be used in evidence of what is required to meet premises standards.

Protection from liability for good faith informants. Section 112(1) provides that a person is not civilly or criminally liable for an act done or omitted in good faith in providing the Pharmacy Committee with information. This protects whistleblowers and witnesses who report concerns about health practitioners or pharmacy operations. However, it does not affect any liability the Territory would otherwise have for the act or omission (subsection (2)). Similarly, section 109 prohibits threatening or intimidating such a person.

Protection from liability for Committee members and delegates. Section 18J(1) protects a member of the Pharmacy Committee, a member of an advisory committee, or a delegate from civil or criminal liability for anything done or omitted in good faith in the exercise of a power or performance of a function. This includes purported exercise or performance (subsection (3)). Again, this does not affect the Territory’s liability (subsection (2)).

Right of appeal to the Tribunal against National Board decisions. While not detailed in this Act, the cross-reference to the Health Practitioner Regulation National Law (NT) in section 64 (Tribunal must hear matters under that Law) and the transitional provisions in Part 13 indicate that appellable decisions (defined in section 154) by a National Board or a panel are subject to appeal. The former Health Professional Review Tribunal (now the Civil and Administrative Tribunal) hears these appeals. The transitional provisions ensure continuity for appeals started before or after the commencement of the Northern Territory Civil and Administrative Tribunal (Conferral of Jurisdiction Amendments) (No. 2) Act 2014.

Rights of persons subject to inspector powers. An inspector must produce their identity card when exercising power (section 72(1)). A person on premises may be questioned (section 73(1)(e)), but answers given under direction (section 108(2)) are not admissible against that person except for perjury (section 108(3)). A person may request a receipt for seized items (section 73(1)(j)). The Pharmacy Committee must provide access to documents removed from premises if the person has legitimate need (section 73(2)).

The Act creates a comprehensive enforcement regime with penalties ranging from minor (5 penalty units for not returning an inspector’s identity card) to severe (2,500 penalty units for a body corporate contravening pharmacy ownership rules). Offences fall into two categories: those in Part 8 (general offences) and those in Schedule 7 (pharmacy-specific offences).

Part 8 Offences include:

• Offences of dishonesty (section 106): knowingly making or giving a statement containing misleading information in connection with an inspector’s investigation carries 100 penalty units or 6 months imprisonment.
• Obstruction (section 107): obstructing, hindering, threatening or intimidating a person exercising a power or function under the Act carries 500 penalty units.
• Failure to assist an inspector (section 108(1)): without reasonable excuse, failing to assist an inspector in an investigation carries 100 penalty units or 6 months imprisonment.
• Threatening or intimidating a person who provides information in good faith (section 109): 500 penalty units.
• Failure to leave proceedings of the Pharmacy Committee when ordered (section 110(1)): 50 penalty units.
• Unauthorised reporting or disclosure of Pharmacy Committee proceedings (section 110(3)): 100 penalty units or 6 months imprisonment.

Schedule 7 Offences cover the substantive pharmacy regulations. Each offence specifies separate maximum penalties for individuals and body corporates:

• Clause 2(1) (owning or controlling a pharmacy business without authorisation): 500 / 2,500 penalty units.
• Clause 3 (owning a pharmacy service without being an authorised provider): 500 / 2,500 penalty units.
• Clause 4(1) and (2) (conducting a pharmacy business or service from non-complying premises): 500 / 2,500 penalty units.
• Clause 5(1) and (2) (failing to ensure direct supervision by a pharmacist): 500 / 2,500 penalty units.
• Clause 6 (entering or remaining in a pharmacy without authorisation): 500 penalty units (applies to individuals, no separate body corporate penalty).
• Clause 7(1) and (3) (opening a pharmacy business or department without a pharmacist-in-charge): 500 / 2,500 penalty units.
• Clause 7(2) and (4) (failing to notify the Pharmacy Committee of appointment of pharmacist-in-charge): 20 / 100 penalty units.
• Clause 8(1) (failing to appoint a pharmacy superintendent for multiple pharmacies): 500 / 2,500 penalty units.
• Clause 8(2) (failing to notify appointment of pharmacy superintendent): 20 / 100 penalty units.
• Clause 9(1) (unauthorised possession of pharmacy keys): 50 penalty units (individual only).
• Clause 10(1) (unauthorised use of titles “pharmacy”, “chemist”, etc.): 25 penalty units (individual only; clause 10(5) says it is a regulatory offence).
• Clause 10(4) (unauthorised use of “pharmacy department” or similar): 25 penalty units (regulatory offence).
• Clause 11 (unconscionable conduct to influence a pharmacist): 400 penalty units (no separate body corporate penalty; but body corporate could be charged under general principles).

Enforcement mechanisms. The Pharmacy Committee administers Schedule 7 and has the function to prosecute offences against it (section 18C(1)(a)(ii)). Inspectors appointed by the Committee have powers under Part 4 to enter premises (with consent or warrant), search, inspect documents, ask questions, seize evidence, and remove documents (section 73). Inspectors may apply to a justice of the peace for a warrant if they cannot reasonably rely on consent or open premises powers (section 72(2)-(5)). When seizing items, inspectors must provide a receipt (section 73(1)(j)). The Pharmacy Committee may retain removed documents as long as necessary, but must provide reasonable access to persons with legitimate need (section 73(2)).

Executive officer liability. Section 127 creates a separate offence for an executive officer of a body corporate where the body corporate contravenes a declared provision (specific Schedule 7 clauses). The executive officer faces the same maximum penalty as an individual would for the relevant offence. This is a regulatory offence (section 127(2)). Defences are available: the officer was not in a position to influence, took reasonable steps, or did not know and could not reasonably have known (section 127(3)). In deciding whether reasonable steps were taken, a court must consider actions taken to ensure compliance assessments, implementation of recommendations, and employee training (section 127(4)). The section applies whether or not the body corporate is prosecuted (section 127(7)). Transitional provisions in section 159 ensure the new section 127 applies only to offences where all conduct (by both the body corporate and the executive officer) occurred after the commencement of the amending Act (14 October 2015). For offences committed wholly before that date, the old version of section 127 continues to apply.

Prohibition on carrying on business after conviction. Section 119 gives the Secretary a powerful enforcement tool: after a person is convicted of an offence against the Act, the Secretary may by written notice prohibit that person from operating a business that provides health care services. The prohibition may be for a fixed period or unlimited with a right to apply for lifting after a specified time (section 119(2)). The Secretary must be of the opinion that the person is not a fit and proper person to operate such a business (section 119(3)). A person convicted of two or more offences within ten years is presumed not fit and proper, absent evidence to the contrary (section 119(4)). The prohibition may be limited to specified premises or premises within a specified area (section 119(5)). Operating a business in contravention of a prohibition is an offence punishable by 500 penalty units (section 119(8)). There is a rebuttable presumption that if health care services are provided on premises where a business is carried on, the business provides those services (section 119(9)). The prohibition has no effect while an appeal against the conviction is pending (section 119(10)). This provision is unique in that it does not require the offence to relate to health care services; any offence against the Act can trigger the prohibition, making it a powerful deterrent.

Time limit for prosecutions. Section 122 provides that a complaint for an offence against the Act may be commenced within three years after the date the offence was committed or within three years after the date the actions constituting the offence were first discovered. This extended limitation period (compared to usual summary offence timeframes) recognises that pharmacy regulation breaches may not be immediately apparent.

Evidential provisions. Section 121 simplifies proof: in any proceedings, proof is not required of the constitution of the Pharmacy Committee, any resolution or decision, the appointment of any member, or the presence of a quorum, unless evidence to the contrary is given. Section 124 allows findings of fact from other proceedings (in any court or tribunal, in the Territory or elsewhere) about a health practitioner’s conduct to be used as evidence in proceedings under this Act. This is particularly useful in disciplinary proceedings where the same conduct has been the subject of court proceedings.

Penalty unit value. While the Act does not specify the dollar amount of a penalty unit, the default under the NT’s Penalty Units Act applies. As of the Act’s currency date (November 2020), a penalty unit was $157 (subject to indexation). A 500 penalty unit fine for an individual would therefore be $78,500; a 2,500 penalty unit fine for a body corporate would be $392,500. Imprisonment terms are specified for some offences (e.g., six months for dishonesty, failure to assist, unauthorised disclosure).

The Health Practitioners Act 2004 does not operate in isolation; it forms part of a larger regulatory ecosystem for health practitioners and pharmacies in the Northern Territory. Its interactions with other legislation are both explicit (through cross-references) and structural (through transitional arrangements that preserved certain regimes during reform).

Health Practitioner Regulation National Law (NT). This is the most significant interaction. The Act cross-references the National Law in multiple places. “Health profession” is defined by reference to section 5 of the National Law (section 4). “Notification” has the same meaning as in the National Law (section 4). “Registered” means registered under the National Law (section 4). “National Board” means a National Board established by section 31 of the National Law (section 4). The Tribunal’s core function is to “hear each matter for which it has functions under the Health Practitioner Regulation National Law (NT)” (section 64). The National Law itself (in section 289 of that Act, referred to in transitional provisions) deals with pending complaints when the National Law commenced. The Act also references the Health Practitioner Regulation (National Uniform Legislation) Act 2010, which is the enabling Act for the National Law in the Territory. The practical effect is that the regulation of individual health practitioners (registration, complaints, disciplinary action) is governed primarily by the National Law, with this Act providing the Tribunal that hears appeals and conducts hearings for the Territory under that Law.

Northern Territory Civil and Administrative Tribunal Act 2014. Since 2014, the Tribunal for purposes of this Act is the Civil and Administrative Tribunal (NTCAT) (section 4 definition of “Tribunal”). Part 13 of this Act contains transitional provisions dealing with the conferral of jurisdiction from the former Health Professional Review Tribunal to NTCAT. Sections 154-158 ensure continuity: appeals against appellable decisions (defined in the National Law) that were started before the commencement continue under the former legislation (section 155); if the process to initiate an appellable decision started before commencement but the decision was made after, the new legislation applies (section 156); matters already before the former Tribunal continue with that tribunal (section 157). This means practitioners, the National Board, and the Tribunal must be aware of which regime applies based on the timing of the decision and appeal.

Health Practitioner (National Uniform Legislation) Implementation Act 2010 and 2012. These Acts are the vehicles that repealed large parts of this Act and transferred functions to the National Law. Part 12 contains detailed transitional provisions. Division 1 (2010 implementation) deals with the first wave of transfers covering professions like medicine, nursing and others. Division 2 (2012 implementation) deals with the transfer of boards for Aboriginal health workers, occupational therapists and radiographers. Key provisions include the treatment of pending complaints before former Boards (sections 146 and 150): the Tribunal must deal with such complaints as if they had been referred by the relevant National Board. Pending information and ombudsman complaints continue under the Information Act 2002 or Ombudsman Act 2009 as if the implementation had not occurred, with references to the former Board substituted with the National Board (sections 147 and 151). Business addresses recorded in registers before commencement are taken to be the health practitioner’s principal place of practice under the National Law (sections 148 and 152). These provisions ensure legal certainty during the transition.

Information Act 2002 and Ombudsman Act 2009. As noted above, sections 147 and 151 preserve the jurisdiction of these Acts for pending matters concerning former Boards. If a person had not yet had an application or complaint under these Acts decided before the implementation day, the relevant Act continues to apply as if the implementation had not occurred, with appropriate substitution of references. This protects the rights of individuals who had sought information or made complaints about the former Boards.

Statute Law Amendment (Directors’ Liability) Act 2015. This Act inserted the current section 127 on executive officer liability and added Part 14 (section 159) to manage the transition. The new section 127 applies only to offences where all conduct (by the body corporate and the executive officer) occurred after 14 October 2015. Offences that span the transition (or where conduct occurred partly before and partly after) continue to be governed by the version of section 127 in force before the amendment. This is a specific example of how amending legislation interacts with the principal Act, requiring careful attention to timing.

Other NT legislation. The Act binds the Crown (section 5), which means it prevails over Crown immunity. The Local Court (Related Amendments) Act 2016 amended sections 72 and Schedule 2 (as noted in the endnotes), likely to reflect changes in court jurisdiction. The Reference to the Justices of the Peace for warrants under section 72 is governed by general NT law on warrants. The criminal law generally (Criminal Code) applies to offences, but the Act creates specific regulatory offences (some with imprisonment) and some are noted as “regulatory offences” (e.g., clause 10(5) for unauthorised titles - a regulatory offence carries no imprisonment, only a fine). The defendant’s liability for the body corporate’s acts is excluded if the body corporate would have a defence (section 127(8)), linking to general criminal defences such as mistake of fact or reasonable excuse.

Pharmacy premises standards. Schedule 7 clause 4 requires compliance with “standards prescribed by the Pharmacy Committee”. These standards are not contained in the Act itself but are made by the Committee (section 18E allows policies and guidelines to give practical guidance). The standards may be legislative instruments or administrative policies, interacting with the Interpretation Act and the Subordinate Legislation Act. Pharmacy operators must look to the Committee’s published standards for specific requirements.

The Health Practitioners Act 2004 has been substantially amended since its enactment, primarily to transfer health practitioner regulatory functions to the national scheme and to update tribunal arrangements. The original Act was assented to on 16 April 2004 and commenced in stages: sections 130 and Schedule 8 on 23 February 2005, with the remainder on 14 May 2004. At that time, the Act established multiple health practitioner boards, a Health Professional Review Tribunal, and comprehensive provisions for registration, complaints and discipline.

Health Practitioner Regulation (National Uniform Legislation) Act 2010 (No. 2, 2010) amended the Act from 1 July 2010 to facilitate the commencement of the National Law in the Territory. It inserted the note to section 64 and made various amendments to sections dealing with the Tribunal and definitions.

Health Practitioner (National Uniform Legislation) Implementation Act 2010 (No. 18, 2010) was the primary vehicle for the first wave of transition. It inserted Part 2A (Pharmacy Premises Committee, sections 18A-18K) and Part 10 (transitional matters, later repealed). It amended the long title, section 3, section 4, and many other sections. It repealed Schedule 1 and substituted Schedule 7 (pharmacy provisions). This Act marked the shift of the Act’s focus from general health practitioner regulation to pharmacy premises regulation. The former health practitioner boards for doctors, nurses, etc., ceased to exist, and their functions were transferred to National Boards.

Health Practitioner (National Uniform Legislation) Implementation Act 2012 (No. 17, 2012) completed the transition for the remaining three boards: Aboriginal Health Workers Board, Occupational Therapists Board, and Radiographers Board. It repealed very large parts of the Act: all of original Parts 2 (except the Pharmacy Committee provisions), original Part 3 (Tribunal provisions, later re-inserted in different form), original Part 4 (Inspectors, re-inserted), original Parts 5-7, original Part 8 Division 1, original Part 9 Division 1 (protection from liability), and Schedules 1, 4-6, 9-10. It re-enacted the Pharmacy Committee provisions (section 18B was substituted), inserted new Part 4 (Inspectors of Pharmacy Committee), substituted Part 8 (Offences), amended Part 9, added a new section 18L (fees), and inserted Division 2 of Part 12 (transitional for 2012 implementation). After this Act, the Health Practitioners Act was almost entirely about pharmacy premises regulation and the Tribunal.

Northern Territory Civil and Administrative Tribunal (Conferral of Jurisdiction Amendments) (No. 2) Act 2014 (No. 35, 2014) substituted the Tribunal provisions (Part 3, sections 63-66) to replace the Health Professional Review Tribunal with the Civil and Administrative Tribunal (NTCAT). It also inserted new sections 65 and 66 (additional notifications and medical examinations), amended sections 100, 108 and 110, and inserted Part 13 (transitional matters for the conferral of jurisdiction). The former sections on appeals, hearings and the former Tribunal were repealed. This was a structural reform to unify tribunal jurisdiction across the Territory.

Statute Law Amendment (Directors’ Liability) Act 2015 (No. 26, 2015) substituted section 127 (executive officer liability) with a new version that clarified the declared provisions, the nature of the offence as a regulatory offence, and the defence framework. It also inserted Part 14 (section 159) to manage the transition between the old and new section 127.

Minor amendments were made by the Legal Profession (Consequential Amendments) Act 2007, Oaths, Affidavits and Declarations (Consequential Amendments) Act 2010, Statute Law Revision Act 2014, Local Court (Related Amendments) Act 2016, and Statute Law Revision Act 2020 (which amended section 18C). These mainly updated references and corrected formal matters.

The cumulative effect of these amendments is that the Act has shrunk from a comprehensive health practitioner regulation statute to a focused Act dealing almost exclusively with pharmacy premises regulation and the Tribunal’s functions under the National Law. The endnotes list detailed amendments, showing the complexity of tracking which provisions are currently in force.

The Act itself does not cite any cases. As an analyst, I cannot invent case law. However, the structure of the Act suggests several potential areas of litigation that have likely arisen in practice but are not recorded in the Act text.

Prosecutions under Schedule 7. The Pharmacy Committee has the function to prosecute offences against Schedule 7 (section 18C(1)(a)(ii)). Given the strict liability nature of many offences (e.g., operating without direct supervision, operating without a pharmacist-in-charge), prosecutions would likely focus on establishing the factual elements: that the premises were a pharmacy, that no pharmacist was present, that the defendant was the owner. Defences of reasonable excuse (where available) or mistake might be litigated. The double conviction presumption under section 119(4) would be relevant in sentencing or prohibition proceedings.

Tribunal hearings under the National Law. The Tribunal (NTCAT) hears matters about registered health practitioners. Given that the Act provides for additional notifications (section 65) and medical examinations (section 66), there may be case law on the circumstances in which additional notifications can be taken up, or the reasonableness of medical examination orders. However, such proceedings typically relate to the National Law, not this Act directly.

Appeals against prohibition orders. Section 119 allows the Secretary to prohibit a convicted person from operating a health care services business. The section provides for an application to lift the prohibition after a specified time (subsection (6)), but does not specify a right of appeal to the Tribunal. A person affected may need to rely on general administrative law remedies (judicial review) to challenge the Secretary’s opinion that they are not fit and proper. The presumption in subsection (4) (two convictions within ten years) could be rebutted by evidence.

Executive officer liability. Since the introduction of the current section 127 in 2015, there may have been prosecutions of executive officers for body corporate offences. The defence of reasonable steps (section 127(3)(b) and (4)) would be a key battleground: what actions did the officer take to ensure compliance? Did they arrange professional assessments, implement recommendations, ensure employee knowledge? The transitional provisions in section 159 create timing issues: if the conduct of the body corporate occurred partly before and partly after the commencement, which version of section 127 applies? This could be litigated.

Evidential use of findings from other proceedings. Section 124 allows a finding of fact from any other proceedings (court or tribunal) about a health practitioner’s conduct to be evidence in proceedings under this Act. This could be used in disciplinary proceedings before the Tribunal, raising issues of procedural fairness and whether the previous finding should be given weight. However, the section does not make the finding conclusive; it is merely evidence.

Regulatory offence classification. Schedule 7 clause 10(5) states that an offence against that clause is a regulatory offence. Other Schedule 7 offences are not labelled. The distinction matters for criminal procedure: regulatory offences typically do not carry imprisonment and may have lower fault elements. The courts may need to determine the mental element (if any) for unlabeled offences under general NT criminal law.

Probative value of certificate evidence. While not explicit, the presumptions in section 121 (no proof required of Committee constitution, appointments, quorum, etc.) would simplify prosecution but could be challenged if evidence to the contrary is given.

Consumer protection claims. While not litigation under this Act, a person who suffers harm due to non-compliant pharmacy operations may bring a civil claim in tort. Section 112 protects informants from liability, but does not protect pharmacy owners from their own negligence. The premises standards under clause 4 may be relevant in establishing a duty of care and breach.

Interaction with the National Law. Practitioners may challenge a National Board’s decision by appealing to the Tribunal. The grounds of appeal are set by the National Law, not this Act, but the Tribunal’s constitution under section 63 (three members) would affect the appeal. The requirement that the health practitioner member have no conditions or undertakings (section 63(1)(b)(ii)) could be litigated if a member with a condition sits.

The Act is not about all health practitioners. Despite its title, the Health Practitioners Act 2004 now primarily regulates pharmacy premises and pharmacy business ownership. The rest of health practitioner regulation (registration, complaints, professional standards) has been transferred to the Health Practitioner Regulation National Law (NT). A reader expecting a general health practitioner code will find only skeleton provisions for the Tribunal and transitional arrangements. Most of the substantive duties for doctors, nurses and allied health professionals are not in this Act.

Ownership restrictions catch landlords and financiers. Clause 2(1) says a person must not “own” or “exercise any control over the conduct of” a pharmacy business. “Own” is not defined. A landlord who leases premises to a pharmacy business and receives rent keyed to profits could be arguing they exercise control. A bank with security over pharmacy assets could be at risk. The definition of “control” is broad. The exemption for administrators of deceased estates, bankrupts and companies in administration (clause 2(5)) suggests that the prohibition is intended to catch true commercial control, but the breadth is concerning. Any person with significant influence over the business should take advice.

The pharmacist-in-charge cannot be appointed for more than one pharmacy. Clause 7(6) flatly prohibits appointing a pharmacist as pharmacist-in-charge of more than one pharmacy or pharmacy department. This prevents a pharmacist from overseeing multiple locations simultaneously, even if the pharmacies are small or adjacent. The only way to cover multiple pharmacies is to appoint a pharmacy superintendent under clause 8, but that does not relieve the owner of the need for a pharmacist-in-charge for each location. The superintendent role is additional, not alternative.

Direct supervision means physical presence. Clause 5 requires a pharmacy to be under the “direct supervision” of a pharmacist at all times while open. The Act does not define “direct supervision”, but the Australian Health Practitioner Regulation Agency (AHPRA) and Pharmacy Board of Australia have issued guidelines. The expectation is that the supervising pharmacist is on the premises and able to immediately control pharmacy operations. Remote supervision via video link is unlikely to satisfy this requirement. The owner bears the absolute duty; if the supervising pharmacist goes on break or leaves early, the owner is in breach even if they did not know.

Key holding obligations apply to all access mechanisms. Clause 9(1) prohibits a person from having “keys” to a pharmacy unless they are a key holder or authorised. “Keys” includes “a device, code and any other mechanism to gain access” (clause 9(3)). This means PIN codes, swipe cards, biometric logins, and master keys are all covered. A delivery person given a code to access a closed pharmacy for restocking could be in breach unless authorised by the key holder. Staff who are not pharmacists or key holders cannot have any means of entry.

Executive officer liability is broad but restricted to specific provisions. Section 127 only applies to declared provisions specified in subsection (9): clauses 2(1), 3, 4(1)/(2), 5(1)/(2), 7(1)/(2)/(3), and 8(1). Importantly, clause 6 (unauthorised entry), clause 9 (keys), clause 10 (titles), and clause 11 (unconscionable conduct) are not declared provisions. Executive officers cannot be liable under section 127 for those offences. Also, the declared provision list can be extended by regulation (clause 9(b)), so the list may change without amending the Act.

The Secretary’s prohibition power is not limited to the convicted person’s own business. Section 119(1) allows the Secretary to prohibit a convicted person from “operating a business that provides health care services”. This could extend to operating a business as an employee, agent or contractor. The prohibition may be limited to specific premises or areas (subsection (5)), but the default is a prohibition on any health care services business. A pharmacist convicted of an offence under the Act (e.g., failing to supervise, even inadvertently) could be barred from any role in pharmacy, including as an employee, until the prohibition is lifted.

Prohibition notices can be issued without a court order. The Secretary acts administratively under section 119. There is no requirement for a hearing before the prohibition is imposed. The only safeguard is that the prohibition has no effect while an appeal against the conviction is pending (subsection (10)). After the appeal period expires, the prohibition takes effect. The convicted person can apply for the prohibition to be lifted after a specified time (if the prohibition is for an unlimited period subject to a right to apply - subsection (2)(b)). But if the prohibition is for a fixed period, there is no right to apply earlier.

Three-year limitation period runs from discovery, not conviction. Section 122 allows proceedings to be commenced within three years after the date the actions constituting the offence were first discovered. This could be many years after the commission of the offence if the conduct was concealed. The Pharmacy Committee and inspectors can investigate historical breaches. This is particularly relevant for ownership or supervision breaches that may continue for years before detection.

Transitional provisions can trap the unwary. A matter that was before the former Health Professional Review Tribunal before June 2015 continues under the old legislation (Part 13, section 157). A person appealing an appellable decision that was made after June 2015 but where the process started before must use the new legislation for the appeal (section 156). The timing of the decision and the appeal period matters. Similarly, the version of section 127 that applies depends on whether the body corporate’s conduct occurred before or after 14 October 2015 (Part 14). Practitioners dealing with historical matters must check which version of the Act applied at the relevant time.

The Act does not specify procedures for the Pharmacy Committee’s own proceedings. While Schedule 3 covers meetings, the Committee can determine its own procedures subject to that Schedule (clause 7(1)). This flexibility means there may not be a published procedural code. Participants in Committee proceedings (including witnesses and subjects of investigation) may lack procedural guidance. The Committee can exclude persons from meetings on compelling grounds (clause 6(2)), which could include the subject of the meeting.

Protection from liability is not absolute. Section 112 protects a person providing information in good faith from civil and criminal liability, but does not protect against defamation claims if the information is false and not made in good faith. Similarly, section 18J protects Committee members in good faith, but the Territory remains liable (subsection 18J(2)). A person harmed by a Committee member’s negligence could sue the Territory.

Regulatory offences have lower fault elements. Several offences (e.g., clause 5, 6, 7(1)) do not state a fault element. Under NT criminal law, this likely means they are strict liability. A person who has taken all reasonable precautions may still be convicted. The only general defence is “reasonable excuse” where the Act provides it (e.g., section 108(1) for failing to assist an inspector). The defences for executive officers under section 127(3) are specific to that section and do not extend to the primary offences.

Compliance with the Health Practitioners Act 2004 requires attention to both the structural requirements for pharmacy ownership and the ongoing operational duties. The Pharmacy Committee has powers to prescribe premises standards (section 18E and Schedule 7 clause 4) and to issue policies and guidelines, so operators must stay up to date with those. The following practical steps are grounded in the Act.

Step 1: Ensure lawful ownership structure. Before acquiring or operating a pharmacy business, confirm that the owner is an authorised pharmacy business owner: an individual pharmacist, a partnership of all pharmacists, or a corporation of which all shareholders and directors are pharmacists (Schedule 7, clause 1 definition). Non-pharmacist investors cannot own shares or be directors. If the pharmacy is part of an Aboriginal health service, a public hospital or a defence force facility, it can be owned by an authorised pharmacy service provider (the organisation itself, not necessarily pharmacist-owned). If the operator wishes to rely on the grandfather exemption for pharmacies owned before 23 February 2005, they must have documentary evidence of that fact (clause 2(4)). For Aboriginal health services or friendly societies, consider applying to the Minister for an exemption under clause 2(2). Review any trust arrangements, lease options, or management agreements that could amount to exercising “control over the conduct” of the business.

Step 2: Ensure premises comply with Committee standards. Clause 4 requires that premises from which a pharmacy business or service is conducted comply with standards prescribed by the Pharmacy Committee. Obtain the current standards from the Committee (likely published on its website per section 18E(2)). Engage a pharmacist or consultant familiar with these standards before fitting out or renovating premises. Document compliance. If the Committee issues a new standard, ensure premises are upgraded within any transitional period.

Step 3: Appoint a pharmacist-in-charge. Before the pharmacy opens to the public, ensure a pharmacist-in-charge is appointed (clause 7(1)). This person must be a registered pharmacist and must not already be the pharmacist-in-charge of another pharmacy (clause 7(6)). The appointment must be notified to the Pharmacy Committee as soon as practicable after it is made (clause 7(2)). Keep a record of the appointment and the date of notification. If the pharmacy is part of a multiple-pharmacy operation, also appoint a pharmacy superintendent under clause 8(1) and notify the Committee (clause 8(2)).

Step 4: Ensure direct supervision by a pharmacist. While the pharmacy is open to the public, there must be a pharmacist on the premises providing direct supervision (clause 5(1)). This means the pharmacist must be physically present and actively overseeing dispensing and supply. Do not rely on remote supervision. Plan shift rosters to ensure continuous coverage. If there is a period when no pharmacist is present (e.g., lunch break), close the pharmacy to the public. The same applies to pharmacy departments (e.g., hospital outpatient pharmacy) while open to dispense (clause 5(2)).

Step 5: Control entry to the pharmacy. Ensure that only pharmacists and persons under the direct supervision of a pharmacist enter the pharmacy area (clause 6). This means non-pharmacist employees (e.g., assistants, cleaners) must be supervised. Delivery personnel and tradespeople must be escorted or given access only when a pharmacist is present. Put up clear signage. Have a protocol for keys (including codes and cards) under clause 9: only the pharmacist-in-charge or a nominated pharmacist key holder may hold keys. Maintain a key register. Revoke keys immediately if a key holder leaves employment or changes role.

Step 6: Comply with title restrictions. Premises should not be described as “pharmacy”, “chemist”, “pharmaceutical chemist”, “pharmacy department” or similar unless they genuinely meet the definition of pharmacy or pharmacy department (clause 10). This extends to signage, advertising, letterheads, websites, and social media. If operating a remote agency or depot, ensure advertisements clearly state it is only an agency/depot and that a full service or pharmacist is not available (clause 10(2)-(3)).

Step 7: Avoid unconscionable conduct. Do not directly or indirectly attempt to influence, coerce, or cause a pharmacist to engage in conduct that contravenes the Act (clause 11). This could include pressure to dispense without supervision, to operate from non-compliant premises, or to bypass ownership rules. This provision applies to anyone, not just owners.

Step 8: Cooperate with inspectors. If an inspector attends the premises, produce the identity card if requested (section 72(1)). The inspector may enter without a warrant if the premises are open for a health care service or with consent. If consent is not given, the inspector may apply for a warrant. Do not obstruct, hinder, threaten or intimidate the inspector (section 107). Answer questions truthfully; a false or misleading statement could be an offence under section 106. If directed to answer a question under section 108(2), the answer cannot be used in other criminal proceedings except for perjury, so it is safer to answer than to risk an offence for failure to assist (section 108(1)). Do not offer any gift, reward or inducement to an inspector (section 72(7) - 400 penalty units or 2 years imprisonment).

Step 9: Manage documents and records. Keep all documents relating to pharmacy operations, including prescriptions, appointment records, and compliance documents. Inspectors may require production and may seize and remove documents (section 73(1)(j)-(k)). If the Pharmacy Committee retains a document, they must provide reasonable access to the person who needs it (section 73(2)). Have a document retention policy that meets the three-year limitation period (section 122) and any professional standards.

Step 10: Maintain accurate records for the Pharmacy Committee. The Committee must keep minutes of its meetings (Schedule 3, clause 4). Members must disclose interests (clause 5). The Committee’s annual report is due before 31 December each year (section 18K). If the Committee delegates powers, the delegation must be in writing (section 18F).

Step 11: Executive officers of body corporate owners. Ensure that the body corporate has robust compliance systems. Section 127(4) sets out factors a court will consider: regular professional assessments of compliance, implementation of recommendations, and ensuring employees, agents and contractors have reasonable knowledge of the declared provisions. Conduct regular audits, provide training, and document all steps. Officers should monitor the provisions specifically declared (clauses 2(1), 3, 4(1)/(2), 5(1)/(2), 7(1)/(2)/(3), 8(1)) and any additional provisions prescribed by regulation. If a contravention occurs, demonstrate that reasonable steps were taken to prevent it.

Step 12: Respond to a prohibition notice. If the Secretary issues a prohibition notice under section 119, ensure the business ceases operation immediately (unless the conviction is under appeal). The prohibition may be limited to specific premises or areas; comply accordingly. If the prohibition is for an unlimited period with a right to apply after a specified time, prepare a submission to the Secretary explaining why the prohibition should be lifted. Provide evidence of rehabilitation, changed circumstances, or that the person is now fit and proper. If the prohibition is for a fixed period, do not operate during that period and do not attempt to circumvent the prohibition through a different business structure.

Step 13: Use the protection for informants. If a person suspects a breach of the Act, they can provide information to the Pharmacy Committee in good faith and be protected from civil or criminal liability (section 112). Make the report in writing. Do not provide false information (section 106). The Act also protects a person from threats or intimidation for providing information (section 109). If threatened, report to police.

Step 14: Understand the Tribunal’s role. If a health practitioner (including a pharmacist) receives an adverse finding from a National Board, they may appeal to the Tribunal. The appeal process is governed by the National Law, not this Act, but the Tribunal’s constitution under section 63 applies. Engage legal representation experienced in NT health tribunal matters. The Tribunal can order a medical examination under section 66; comply with that order or seek legal advice if challenging its reasonableness. The Tribunal may also add new notifications under section 65; be prepared to address all concerns in one hearing.